000 01273 a2200349 4500
005 20250517201836.0
264 0 _c20190412
008 201904s 0 0 eng d
022 _a1875-5631
024 7 _a10.2174/1566523218666180214092536
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhuang, Quan
245 0 0 _aCX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
_h[electronic resource]
260 _bCurrent gene therapy
_c2017
300 _a442-452 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCX3C Chemokine Receptor 1
_xmetabolism
650 0 4 _aChemokine CX3CL1
_xmetabolism
650 0 4 _aDiabetic Nephropathies
_xmetabolism
650 0 4 _aGlomerulonephritis, IGA
_xmetabolism
650 0 4 _aGraft Rejection
650 0 4 _aHumans
650 0 4 _aKidney Diseases
_xetiology
650 0 4 _aKidney Neoplasms
_xmetabolism
650 0 4 _aLupus Nephritis
_xmetabolism
650 0 4 _aSepsis
_xcomplications
700 1 _aCheng, Ke
700 1 _aMing, Yingzi
773 0 _tCurrent gene therapy
_gvol. 17
_gno. 6
_gp. 442-452
856 4 0 _uhttps://doi.org/10.2174/1566523218666180214092536
_zAvailable from publisher's website
999 _c28089038
_d28089038